Dr. Peter Houghton will lead the research collaboration for GCCRI and is widely regarded as a leading expert in pediatric cancer research and in the development of novel approaches to treating childhood cancers
The entire integration and transition of the brands is expected to be completed by March 2022
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
Subscribe To Our Newsletter & Stay Updated
